Related Experiment Video
Updated: Jul 4, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Exposure to prescribed medication in early life and impacts on gut microbiota and disease development
Huan Huang1,2, Jiayin Jiang1, Xinyu Wang1
1Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China.
Insights
Early-life medication exposure can disrupt infant gut microbiota development, impacting long-term health. This review explores interventions like probiotics and dietary therapy to mitigate these effects.
Area of Science:
- Microbiology
- Developmental Biology
- Pharmacology
Background:
- The gut microbiota is critical for infant development, metabolism, and immunity.
- Early-life pharmaceutical exposure can alter gut microbiota structure and function.
- These alterations may negatively impact later health outcomes.
Purpose of the Study:
- To review the establishment of healthy gut microbiota in early life.
- To summarize common early-life medications and their impact on gut microbiota.
- To discuss disease pathways linked to medication-induced microbiota changes.
Main Methods:
- Literature review of early-life gut microbiota establishment.
- Summary of commonly prescribed medications during pregnancy, childbirth, and infancy.
- Analysis of disease associations with medication-induced gut microbiota alterations.
Main Results:
- Common medications like antibiotics and acid suppressants alter gut microbiota composition.
- Medication-induced dysbiosis is implicated in infections, IBD, metabolic, allergic, and neurodevelopmental disorders.
- Various therapeutic strategies can potentially restore gut microbiota balance.
Conclusions:
- Early-life pharmaceutical exposure poses risks to gut microbiota and subsequent health.
- Interventions including dietary therapy, probiotics, prebiotics, and FMT offer potential preventive strategies.
- Further research is needed to develop targeted approaches for mitigating medication-induced adverse effects.
Abstract:
The gut microbiota during early life plays a crucial role in infant development. This microbial-host interaction is also essential for metabolism, immunity, and overall human health in later life. Early-life pharmaceutical exposure, mainly referring to exposure during pregnancy, childbirth, and infancy, may change the structure and function of gut microbiota and affect later human health. In this Review, we describe how healthy gut microbiota is established in early life. We summarise the commonly prescribed medications during early life, including antibiotics, acid suppressant medications and other medications such as antidepressants, analgesics and steroid hormones, and discuss how these medication-induced changes in gut microbiota are involved in the pathological process of diseases, including infections, inflammatory bowel disease, metabolic diseases, allergic diseases and neurodevelopmental disorders. Finally, we review some critical methods such as dietary therapy, probiotics, prebiotics, faecal microbiota transplantation, genetically engineered phages, and vagus nerve stimulation in early life, aiming to provide a new strategy for the prevention of adverse health outcomes caused by prescribed medications exposure in early life.
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Factors Affecting Drug Response: Overview
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

